EFF Calls For Motsoaledi’s Resignation Over R15.5bn ARV Tender Irregularities
The Economic Freedom Fighters (EFF) has called for the immediate resignation of Health Minister Dr Aaron Motsoaledi following a Pretoria High Court judgment that declared major parts of the Department of Health’s R15.5 billion antiretroviral (ARV) tender unlawful and unconstitutional.
Acting Judge Graham Girdwood handed down the judgment on 20 October 2026, setting aside two contracts worth approximately R12.6 billion for one-month and three-month packs of tenofovir, lamivudine and dolutegravir (TLD), South Africa’s first-line HIV treatment.
The court ordered the department to re-evaluate the affected bids and redo the awards within 120 days following a legal challenge by Cipla Medpro Manufacturing, which argued that it had been unfairly excluded.
The judgment found that Innovata Pharmaceuticals and Viatris Healthcare had relied on an expired manufacturing licence for their Isando facility when submitting their bids. Both companies were excluded from the re-evaluation.
The court also identified irregularities in the allocation of local manufacturing preference and historically disadvantaged individual (HDI) points. It directed the department to investigate whether Barrs Pharmaceuticals and Innovata prepared their bids independently, given their links through Avacare Health Group.
Motsoaledi and the department’s then Director-General were ordered to pay Cipla’s legal costs.
To prevent medication shortages, existing suppliers will continue deliveries during the transition to new contracts.
The EFF said it had raised concerns about the tender as early as February 2026, questioning common ownership among companies, near-identical pricing and whether proper financial due diligence had been conducted.
The party also accused Motsoaledi of distancing himself from the procurement process by saying he relied on departmental officials to handle tenders.
In its statement today, Wednesday, the EFF demanded an immediate SIU investigation into the tender, a Competition Commission probe into possible collusion, the release of evaluation and due-diligence reports, and accountability for officials implicated in the irregularities.
It also called for guarantees that ARV supplies would remain uninterrupted and faster progress towards establishing state pharmaceutical manufacturing capacity.
The tender controversy was again raised in Parliament this week, with MPs questioning the lack of disciplinary action against officials involved in the procurement process.
- Aaron Motsoaledi resignation, Cipla Medpro Manufacturing, Competition Commission probe, EFF ARV tender, HIV treatment procurement, Innovata Pharmaceuticals, MDNTV, mdntvlive, mdntvnews, Motsoaledi ARV tender irregularities, Pretoria High Court judgment, R15.5bn ARV tender, SIU investigation, tenofovir lamivudine dolutegravir, Viatris Healthcare